Citations (99)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (15)
Nakhleh E Abu-Yaghi, Alaa M Abed, Dana F Khlaifat, Mohammed B Nawaiseh, Laith O Emoush, Heba Z AlHajjaj, Ala M Abojaradeh, Mariana N Hattar, Sura K Abusaleem, Hashem M Sabbagh, Yazan A Abu Gharbieh & Sura A Quaqazeh. (2020) Factors Affecting Compliance to Anti-Vascular Endothelial Growth Factor Treatment of Diabetic Macular Edema in a Cohort of Jordanian Patients. Clinical Ophthalmology 14, pages 921-929.
Read now
Read now
Rohit Varma, Neil M Bressler, Quan V Doan, Ivan J Suñer, Mark Danese, Chantal M Dolan, Abraham Lee, Jason S Ehrlich & Yamina Rajput. (2020) Diabetic Population-Based Model to Estimate Impact of Ranibizumab on Diabetic Retinopathy Severity in Patients with Diabetic Macular Edema. Clinical Ophthalmology 14, pages 1249-1259.
Read now
Read now
Nancy Holekamp, Steven B. Duff, Yamina Rajput & Vincent Garmo. (2020) Cost-effectiveness of ranibizumab and aflibercept to treat diabetic macular edema from a US perspective: analysis of 2-year Protocol T data. Journal of Medical Economics 23:3, pages 287-296.
Read now
Read now
Shwu-Jiuan Sheu, Cheng-Kuo Cheng, Hsi-Kung Kuo, Ching-Yao Tsai, Tai-Chi Lin, Jonathan Tan, Hitesh Chandwani, Michael Adena & Shih-Jen Chen. (2018) Treatment patterns in diabetic macular edema in Taiwan: a retrospective chart review. Clinical Ophthalmology 12, pages 2189-2198.
Read now
Read now
Mehmet Tetikoğlu, Serdar Aktas, Hacı Murat Sagdık, Sıla Tasdemir Yigitoglu & Fatih Özcura. (2017) Mean Platelet Volume is Associated with Diabetic Macular Edema in Patients with Type-2 Diabetes Mellitus. Seminars in Ophthalmology 32:5, pages 651-654.
Read now
Read now
Szilárd Kiss, Hitesh S Chandwani, Ashley L Cole, Vaishali D Patel, Orsolya E Lunacsek & Pravin U Dugel. (2016) Comorbidity and health care visit burden in working-age commercially insured patients with diabetic macular edema. Clinical Ophthalmology 10, pages 2443-2453.
Read now
Read now
Sobha Sivaprasad & Sesan Oyetunde. (2016) Impact of injection therapy on retinal patients with diabetic macular edema or retinal vein occlusion. Clinical Ophthalmology 10, pages 939-946.
Read now
Read now
Anna Bong, Michael J Doughty, Norman F Button & David C Mansfield. (2016) On the relationship between visual acuity and central retinal (macular) thickness after interventions for macular oedema in diabetics: a review. Clinical and Experimental Optometry 99:6, pages 491-497.
Read now
Read now
Stephane A Régnier, William Malcolm, Jennifer Haig & Weiguang Xue. (2015) Cost-effectiveness of ranibizumab versus aflibercept in the treatment of visual impairment due to diabetic macular edema: a UK healthcare perspective. ClinicoEconomics and Outcomes Research 7, pages 235-247.
Read now
Read now
Aniruddha Agarwal, Mohamed K Soliman, Yasir J Sepah, Diana V Do & Quan Dong Nguyen. (2014) Diabetic retinopathy: variations in patient therapeutic outcomes and pharmacogenomics. Pharmacogenomics and Personalized Medicine 7, pages 399-409.
Read now
Read now
Jianbo Li, Hongman Zhang, Min Shi, Lingfei Yan & Min Xie. (2014) Homocysteine is Linked to Macular Edema in Type 2 Diabetes. Current Eye Research 39:7, pages 730-735.
Read now
Read now
Michael W Stewart. (2014) Pharmacokinetics, pharmacodynamics and pre-clinical characteristics of ophthalmic drugs that bind VEGF. Expert Review of Clinical Pharmacology 7:2, pages 167-180.
Read now
Read now
Aljoscha S Neubauer, Julian Langer, Raffael Liegl, Christos Haritoglou, Armin Wolf, Igor Kozak, Florian Seidensticker, Michael Ulbig, William R Freeman, Anselm Kampik & Marcus Kernt. (2013) Navigated macular laser decreases retreatment rate for diabetic macular edema: a comparison with conventional macular laser. Clinical Ophthalmology 7, pages 121-128.
Read now
Read now
Michael Wesley Stewart. (2013) PDGF: ophthalmology's next great target. Expert Review of Ophthalmology 8:6, pages 527-537.
Read now
Read now
Douglas R Jeffery, Clyde E Markowitz, Anthony T Reder, Bianca Weinstock-Guttman & Kathy Tobias. (2011) Fingolimod for the treatment of relapsing multiple sclerosis. Expert Review of Neurotherapeutics 11:2, pages 165-183.
Read now
Read now
Articles from other publishers (84)
Lloyd Paul AielloCris Martin P. Jacoba, Mohamed AshrafJerry D. CavalleranoAnn M. Tolson, Dorothy Tolls, Jennifer K. SunPaolo S. Silva. (2023) INTEGRATING MACULAR OPTICAL COHERENCE TOMOGRAPHY WITH ULTRAWIDE-FIELD IMAGING IN A DIABETIC RETINOPATHY TELEMEDICINE PROGRAM USING A SINGLE DEVICE. Retina 43:11, pages 1928-1935.
Crossref
Crossref
Jing Wu, Clive Adams, Xiaoning He, Fang Qi & Jun Xia. (2023) Diversity when interpreting evidence in network meta-analyses (NMAs) on similar topics: an example case of NMAs on diabetic macular oedema. Systematic Reviews 12:1.
Crossref
Crossref
Puren Isik, Selcuk Sizmaz, Ebru Esen, Anıl Uysal & Nihal Demircan. (2023) Comparison of intravitreal ranibizumab and aflibercept for the treatment of diabetic macular edema: a real-world study. International Ophthalmology.
Crossref
Crossref
Sophie J. Bakri, Marie-Noelle Delyfer, Jakob Grauslund, Steffen Andersen & Helene Karcher. (2023) Real-World Persistence and Treatment Interval in Patients with Diabetic Macular Edema Treated with Anti-Vascular Endothelial Growth Factors in the USA. Ophthalmology and Therapy.
Crossref
Crossref
Md Tahir Nursyafiqah, Ab Hamid Siti‐Azrin, Najib Majdi Yaacob, Wan‐Adnan Wan‐Nor‐Asyikeen & Embong Zunaina. (2023) Factors affecting central macular thickness of diabetic macular oedema patients after an induction treatment of intravitreal ranibizumab. Tropical Medicine & International Health 28:4, pages 300-307.
Crossref
Crossref
Jingjing Wang, Shuyu Feng, Qian Zhang, Huan Qin, Chunxiu Xu, Xuefei Fu, Lin Yan, Yaqin Zhao & Kai Yao. (2023) Roles of Histone Acetyltransferases and Deacetylases in the Retinal Development and Diseases. Molecular Neurobiology 60:4, pages 2330-2354.
Crossref
Crossref
Martina Zavorkova, Jana Nekolova, Lidmila Prochazkova, Eva Cermakova & Nada Jiraskova. (2023) Diabetic macular edema treatment with subthreshold micropulse laser - five-year long monitoring. Biomedical Papers 167:1, pages 74-79.
Crossref
Crossref
Tien-En Tan & Tien Yin Wong. (2023) Diabetic retinopathy: Looking forward to 2030. Frontiers in Endocrinology 13.
Crossref
Crossref
Yifan Wu, Huixin Lan, Deju Zhang, Ziyan Hu, Jing Zhang, Zhangwang Li, Panpan Xia, Xiaoyi Tang, Xia Cai & Peng Yu. (2022) Research progress on ncRNAs regulation of mitochondrial dynamics in diabetes. Journal of Cellular Physiology 237:11, pages 4112-4131.
Crossref
Crossref
Ying Yan, Li Zhu, Miao Zeng, Zhijian Huang, Qin Ding, Yang Liu, Chengyuan Gao, Doudou Yu & Xiao Chen. (2022) COMBINATION OF VITRECTOMY AND INTENTIONAL MACULAR DETACHMENT IS ASSOCIATED WITH A FASTER EDEMATOUS REGRESSION THAN VITRECTOMY ALONE IN THE TREATMENT OF REFRACTORY DIABETIC MACULAR EDEMA. Retina 42:10, pages 1859-1866.
Crossref
Crossref
Imoro Zeba Braimah & Winfried M. Amoaku. (2022) Use of ziv-aflibercept in diabetic macular edema in a Ghanaian population. Eye 36:S1, pages 40-44.
Crossref
Crossref
Ogugua Ndubuisi Okonkwo, Toyin Akanbi & Chineze Thelma Agweye. 2022. Diabetic Eye Disease - From Therapeutic Pipeline to the Real World. Diabetic Eye Disease - From Therapeutic Pipeline to the Real World.
Tunde Peto, Toks Akerele, Alexandros Sagkriotis, Sofia Zappacosta, Andreas Clemens & Usha Chakravarthy. (2021) Treatment patterns and persistence rates with anti‐vascular endothelial growth factor treatment for diabetic macular oedema in the UK: A real‐world study. Diabetic Medicine 39:4.
Crossref
Crossref
M.Yu. Frolov, A.S. Salasyuk & V.A. Rogov. (2022) Pharmacoeconomic analysis of brolucizumab therapy in patients with diabetic macular edema. Medical Technologies. Assessment and Choice:4, pages 63.
Crossref
Crossref
Hajar Danesh, Keivan Maghooli, Alireza Dehghani & Rahele Kafieh. (2021) Synthetic OCT data in challenging conditions: three-dimensional OCT and presence of abnormalities. Medical & Biological Engineering & Computing 60:1, pages 189-203.
Crossref
Crossref
Andreia Marisa Penso Pereira, Raul Manuel da Silva Laureano & Fernando Buarque de Lima Neto. (2021) Five regions, five retinopathy screening programmes: a systematic review of how Portugal addresses the challenge. BMC Health Services Research 21:1.
Crossref
Crossref
Xi Yao, Xiaoting Pei, Yingrui Yang, Hongmei Zhang, Mengting Xia, Ranran Huang, Yuming Wang & Zhijie Li. (2021) Distribution of diabetic retinopathy in diabetes mellitus patients and its association rules with other eye diseases. Scientific Reports 11:1.
Crossref
Crossref
Igor Kozak, Avinash Gurbaxani, Ammar Safar, Prasan Rao, Amal Masalmeh, Hazar Assaf, Mohamed Farghaly, Prathamesh Pathak, Ashok Natarajan & Insaf Saffar. (2021) Treatment patterns in patients with age-related macular degeneration and diabetic macular edema: A real-world claims analysis in Dubai. PLOS ONE 16:7, pages e0254569.
Crossref
Crossref
Chad Andrews, Pradeepa Yoganathan & Jennifer A. Pereira. (2021) Blind Spots: Gaps in Disease Knowledge and the Role of Patient Education for Canadians With Diabetic Macular Edema. Canadian Journal of Diabetes 45:4, pages 375-378.
Crossref
Crossref
Ha-Lim Jeon, Hyesung Lee, Dongwon Yoon, Yeonkyung Lee, Jae Hui Kim, Donghyun Jee & Ju-Young Shin. (2020) Burden of diabetic macular oedema in patients receiving antivascular endothelial growth factor therapy in South Korea: a healthcare resource use and cost analysis. BMJ Open 10:12, pages e042484.
Crossref
Crossref
Monique A. Rose, Meri Vukicevic & Konstandina Koklanis. (2020) Adherence of patients with diabetic macular oedema to intravitreal injections: A systematic review. Clinical & Experimental Ophthalmology 48:9, pages 1286-1298.
Crossref
Crossref
Heeyoon Cho, Mina Hwang, Eun H. Hong, Hyoseon Yu, Hyun‐Hee Park, Seong‐Ho Koh & Yong U. Shin. (2020)
Micro‐
RNAs
in the aqueous humour of patients with diabetic macular oedema
. Clinical & Experimental Ophthalmology 48:5, pages 624-635.
Crossref
Crossref
O. A. E. Cooper, D. J. Taylor, D. P. Crabb, D. A. Sim & H. McBain. (2019) Psychological, social and everyday visual impact of diabetic macular oedema and diabetic retinopathy: a systematic review. Diabetic Medicine 37:6, pages 924-933.
Crossref
Crossref
Quan Dong Nguyen, Yasir J. Sepah, Brian Berger, David Brown, Diana V. Do, Alberto Garcia-Hernandez, Sunil Patel, Firas M. Rahhal, Yevgeniy Shildkrot & Ronny W. Renfurm. (2019) Primary outcomes of the VIDI study: phase 2, double-masked, randomized, active-controlled study of ASP8232 for diabetic macular edema. International Journal of Retina and Vitreous 5:1.
Crossref
Crossref
HyunJeong Cho, Kyung Seek Choi, Joo Yong Lee, Donghwan Lee, Nam-Kyong Choi, YouKyung Lee & SeungJin Bae. (2019) Healthcare resource use and costs of diabetic macular oedema for patients with antivascular endothelial growth factor versus a dexamethasone intravitreal implant in Korea: a population-based study. BMJ Open 9:9, pages e030930.
Crossref
Crossref
Krystal Khoo, Ryan E. K. Man, Gwyn Rees, Preeti Gupta, Ecosse L. Lamoureux & Eva K. Fenwick. (2019) The relationship between diabetic retinopathy and psychosocial functioning: a systematic review. Quality of Life Research 28:8, pages 2017-2039.
Crossref
Crossref
Hiroko TerasakiKunihiko ShirakiMasahito OhjiCarola MetzigThomas SchmelterOliver ZeitzOlaf SowadeMasato KobayashiRobert Vitti, Alyson Berliner & Fumio Shiraga. (2019) EFFICACY AND SAFETY OUTCOMES OF INTRAVITREAL AFLIBERCEPT FOCUSING ON PATIENTS WITH DIABETIC MACULAR EDEMA FROM JAPAN. Retina 39:5, pages 938-947.
Crossref
Crossref
Alexandr Stepanov & Jan Studnička. (2019) Use of anti‑VEGF drugs in ophthalmology. Klinická farmakologie a farmacie 33:1, pages 19-24.
Crossref
Crossref
Marc Figueras-Roca, Anna Sala-Puigdollers, Javier Zarranz-Ventura, Carmen Alba-Linero, Socorro Alforja, Cristina Esquinas, Blanca Molins & Alfredo Adán. (2019) Anatomic Response to Intravitreal Dexamethasone Implant and Baseline Aqueous Humor Cytokine Levels in Diabetic Macular Edema. Investigative Opthalmology & Visual Science 60:5, pages 1336.
Crossref
Crossref
Yan Shao, Li-jie Dong, Yusuke Takahashi, Jianglei Chen, Xun Liu, Qian Chen, Jian-xing Ma & Xiao-rong Li. (2019) miRNA-451a regulates RPE function through promoting mitochondrial function in proliferative diabetic retinopathy. American Journal of Physiology-Endocrinology and Metabolism 316:3, pages E443-E452.
Crossref
Crossref
D. V. Lipatov & O. I. Lyshkanets. (2019) Intravitreal therapy of diabetic macular edema in Russian Federation: current state of the problem. Vestnik oftal'mologii 135:4, pages 128.
Crossref
Crossref
Alfonso Giovannini, Mariacristina Parravano, Federico Ricci & Francesco Bandello. (2018) Management of diabetic macular edema with intravitreal dexamethasone implants: Expert recommendations using a Delphi-based approach. European Journal of Ophthalmology 29:1, pages 82-91.
Crossref
Crossref
Emilia Maggio, Mauro Sartore, Marcella Attanasio, Giorgia Maraone, Massimo Guerriero, Antonio Polito & Grazia Pertile. (2018) Anti–Vascular Endothelial Growth Factor Treatment for Diabetic Macular Edema in a Real-World Clinical Setting. American Journal of Ophthalmology 195, pages 209-222.
Crossref
Crossref
D. Cavan, L.E. Makaroff, J. da Rocha Fernandes, S. Karuranga, M. Sylvanowicz, J. Conlon, D. Chaney, A. Malhi & J. Barratt. (2018) Global perspectives on the provision of diabetic retinopathy screening and treatment: Survey of health care professionals in 41 countries. Diabetes Research and Clinical Practice 143, pages 170-178.
Crossref
Crossref
Eva K Fenwick, Grand H-L Cheng, Ryan E K Man, Jyoti Khadka, Gwyn Rees, Tien Y Wong, Konrad Pesudovs & Ecosse Luc Lamoureux. (2018) Inter-relationship between visual symptoms, activity limitation and psychological functioning in patients with diabetic retinopathy. British Journal of Ophthalmology 102:7, pages 948-953.
Crossref
Crossref
Moneeza K. Siddiqui, Gwen Kennedy, Fiona Carr, Alexander S. F. Doney, Ewan R. Pearson, Andrew D. Morris, Toby Johnson, Megan M. McLaughlin, Rachel E. Williams & Colin N. A. Palmer. (2018) Lp-PLA2 activity is associated with increased risk of diabetic retinopathy: a longitudinal disease progression study. Diabetologia 61:6, pages 1344-1353.
Crossref
Crossref
Gabriel Costa de Andrade, João Rafael de Oliveira Dias, André Maia, Michel Eid Farah, Carsten H. Meyer & Eduardo Buchele Rodrigues. (2018) Intravitreal Ziv-Aflibercept for Diabetic Macular Edema: 48-Week Outcomes. Ophthalmic Surgery, Lasers and Imaging Retina 49:4, pages 245-250.
Crossref
Crossref
Suzanne Broadgate, Christine Kiire, Stephanie Halford & Victor Chong. (2018) Diabetic macular oedema: under‐represented in the genetic analysis of diabetic retinopathy. Acta Ophthalmologica 96:A111, pages 1-51.
Crossref
Crossref
D. Cavan, L. Makaroff, J. da Rocha Fernandes, M. Sylvanowicz, P. Ackland, J. Conlon, D. Chaney, A. Malhi & J. Barratt. (2017) The Diabetic Retinopathy Barometer Study: Global perspectives on access to and experiences of diabetic retinopathy screening and treatment. Diabetes Research and Clinical Practice 129, pages 16-24.
Crossref
Crossref
R Gale, P H Scanlon, M Evans, F Ghanchi, Y Yang, G Silvestri, M Freeman, A Maisey & J Napier. (2017) Action on diabetic macular oedema: achieving optimal patient management in treating visual impairment due to diabetic eye disease. Eye 31:S1, pages S1-S20.
Crossref
Crossref
Samuel H. Yun & Ron A. Aldeman. (2017) Highlights over Laser Treatment for Diabetic Retinopathy. Highlights of Ophthalmology 45:2ENG, pages 11-19.
Crossref
Crossref
Marc Figueras-Roca, Blanca Molins, Anna Sala-Puigdollers, Jessica Matas, Irene Vinagre, José Ríos & Alfredo Adán. (2017) Peripheral blood metabolic and inflammatory factors as biomarkers to ocular findings in diabetic macular edema. PLOS ONE 12:3, pages e0173865.
Crossref
Crossref
Michael W. StewartMichael W. Stewart. 2017. Diabetic Retinopathy. Diabetic Retinopathy
257
268
.
Georgia Kourlaba, John Relakis, Ronan Mahon, Maria Kalogeropoulou, Georgia Pantelopoulou, Olga Kousidou & Nikos Maniadakis. (2016) Cost-utility of ranibizumab versus aflibercept for treating Greek patients with visual impairment due to diabetic macular edema. Cost Effectiveness and Resource Allocation 14:1.
Crossref
Crossref
Therese Granström, Henrietta Forsman, Anna Lindholm Olinder, Dimitrios Gkretsis, Jan W. Eriksson, Elisabet Granstam & Janeth Leksell. (2016) Patient-reported outcomes and visual acuity after 12 months of anti-VEGF-treatment for sight-threatening diabetic macular edema in a real world setting. Diabetes Research and Clinical Practice 121, pages 157-165.
Crossref
Crossref
Danielle Desjardins, Yueying Liu, Craig E. Crosson & Zsolt Ablonczy. (2016) Histone Deacetylase Inhibition Restores Retinal Pigment Epithelium Function in Hyperglycemia. PLOS ONE 11:9, pages e0162596.
Crossref
Crossref
Charles C. Wykoff, Michael J. Elman, Carl D. Regillo, Beiying Ding, Na Lu & Ivaylo Stoilov. (2016) Predictors of Diabetic Macular Edema Treatment Frequency with Ranibizumab During the Open-Label Extension of the RIDE and RISE Trials. Ophthalmology 123:8, pages 1716-1721.
Crossref
Crossref
Christian Prünte, Franck Fajnkuchen, Sajjad Mahmood, Federico Ricci, Katja Hatz, Jan Studnička, Vladimir Bezlyak, Soumil Parikh, William John Stubbings, Andreas Wenzel & João Figueira. (2016) Ranibizumab 0.5 mg treat-and-extend regimen for diabetic macular oedema: the RETAIN study. British Journal of Ophthalmology 100:6, pages 787-795.
Crossref
Crossref
Napoleone Ferrara & Anthony P. Adamis. (2016) Ten years of anti-vascular endothelial growth factor therapy. Nature Reviews Drug Discovery 15:6, pages 385-403.
Crossref
Crossref
Charles C. Wykoff & Seenu M. Hariprasad. (2016) DRCR Protocol-T: Reconciling 1- and 2-Year Data for Managing Diabetic Macular Edema. Ophthalmic Surgery, Lasers and Imaging Retina 47:4, pages 308-312.
Crossref
Crossref
Carmen A. Puliafito, Scott W. CousinsJason BacharachVictor H. GonzalezNancy M. HolekampPauline T. MerrillMatthew P. OhrRichard K. ParrishIIIIChristopher D. Riemann. (2016) Forming a Consensus: Data and Guidance for Physicians Treating Diabetic Macular Edema. Ophthalmic Surgery, Lasers and Imaging Retina 47:4.
Crossref
Crossref
Nancy Binda, Charles Porto Petruceli Carayon, Rafael Agostini, Ana do Nascimento Pinheiro, Marta Nascimento Cordeiro, Marco Romano Silva, Juliana Figueira Silva, Elizete Rita Pereira, Claudio da Silva Junior, Célio de Castro Junior, Andre Sena Guimarães & Marcus Gomez. (2016) PhTx3-4, a Spider Toxin Calcium Channel Blocker, Reduces NMDA-Induced Injury of the Retina. Toxins 8:3, pages 70.
Crossref
Crossref
Pravin U. Dugel, Andrew Layton & Rohit Varma. (2016) Diabetic Macular Edema Diagnosis and Treatment in the Real World: An Analysis of Medicare Claims Data (2008 to 2010). Ophthalmic Surgery, Lasers and Imaging Retina 47:3, pages 258-267.
Crossref
Crossref
Ayhan Dursun, Ayşe Vural Ozec, Kadir Kirboga, Feyza Gulac Dursun, Mustafa Ilker Toker, Haydar Erdogan & Mustafa Kemal Arici. (2015) Evaluation of Inner and Outer Retinal Thickness in Patients Receiving Intravitreal Ranibizumab Injections for Diabetic Macular Edema. European Journal of Ophthalmology 26:1, pages 48-53.
Crossref
Crossref
Chin-Boon Chng, Yvonne Ho & Chee-Kong Chui. (2015) Automation of retinal surgery: A shared control robotic system for laser ablation. Automation of retinal surgery: A shared control robotic system for laser ablation.
Christopher J. Wallick, Ryan N. Hansen, Joanna Campbell, Szilárd Kiss, Jonathan W. Kowalski & Sean D. Sullivan. (2015) Comorbidity and Health Care Resource Use Among Commercially Insured Non-Elderly Patients With Diabetic Macular Edema. Ophthalmic Surgery, Lasers and Imaging Retina 46:7, pages 744-751.
Crossref
Crossref
Tatsuro Ishibashi, Xiaoxin Li, Adrian Koh, Timothy Y.Y. Lai, Fenq-Lih Lee, Won-Ki Lee, Zhizhong Ma, Masahito Ohji, Nikolle Tan, Sung Bok Cha, Jila Shamsazar & C. Lillian Yau. (2015) The REVEAL Study. Ophthalmology 122:7, pages 1402-1415.
Crossref
Crossref
Denis Jusufbegovic, Mark O. Mugavin & Shlomit Schaal. (2015) EVOLUTION OF CONTROLLING DIABETIC RETINOPATHY. Retina 35:5, pages 929-934.
Crossref
Crossref
Charles C. Wykoff & Seenu M. Hariprasad. (2015) Comparing aflibercept, bevacizumab, and ranibizumab for DME: Analysis of DRCR Protocol T. Ophthalmic Surgery, Lasers and Imaging Retina 46:3, pages 302-305.
Crossref
Crossref
Ugo Menchini, Francesco Bandello, Vincenzo De Angelis, Federico Ricci, Luigi Bonavia, Francesco Viola, Elisa Muscianisi & Massimo Nicolò. (2015) Ranibizumab for Visual Impairment due to Diabetic Macular Edema: Real-World Evidence in the Italian Population (PRIDE Study). Journal of Ophthalmology 2015, pages 1-10.
Crossref
Crossref
Fabio Patelli & Stanislao Rizzo. 2015. Management of Complicated Vitreoretinal Diseases. Management of Complicated Vitreoretinal Diseases
189
197
.
Yasha S Modi, Paula E Pecen & Andrew P Schachat. 2015. Managing Diabetic Eye Disease in Clinical Practice. Managing Diabetic Eye Disease in Clinical Practice
81
103
.
Raffael Liegl, Julian Langer, Florian Seidensticker, Lukas Reznicek, Christos Haritoglou, Michael W. Ulbig, Aljoscha S. Neubauer, Anselm Kampik & Marcus Kernt. (2014) Comparative Evaluation of Combined Navigated Laser Photocoagulation and Intravitreal Ranibizumab in the Treatment of Diabetic Macular Edema. PLoS ONE 9:12, pages e113981.
Crossref
Crossref
Charmaine S. Ng, Joyce Y.C. Lee, Matthias PHS Toh & Yu Ko. (2014) Cost-of-illness studies of diabetes mellitus: A systematic review. Diabetes Research and Clinical Practice 105:2, pages 151-163.
Crossref
Crossref
Amir Farshchi, Alireza Esteghamati, Ali Akbari Sari, Abbas Kebriaeezadeh, Mohammad Abdollahi, Farid Abedin Dorkoosh, Mohamad Ebrahim Khamseh, Rokhsareh Aghili, Abbas Keshtkar & Maryam Ebadi. (2014) The cost of diabetes chronic complications among Iranian people with type 2 diabetes mellitus. Journal of Diabetes & Metabolic Disorders 13:1.
Crossref
Crossref
Francesco Bandello, Chiara Preziosa, Giuseppe Querques & Rosangela Lattanzio. (2014) Update of Intravitreal Steroids for the Treatment of Diabetic Macular Edema. Ophthalmic Research 52:2, pages 89-96.
Crossref
Crossref
Young Gun Park, Eun Yeong Kim & Young Jung Roh. (2014) Laser-Based Strategies to Treat Diabetic Macular Edema: History and New Promising Therapies. Journal of Ophthalmology 2014, pages 1-9.
Crossref
Crossref
Andrew R. H. Simpson & Timothy L. Jackson. 2014. Diseases of the Vitreo-Macular Interface. Diseases of the Vitreo-Macular Interface
7
19
.
Joshua D. Stein, Paula Anne Newman-Casey, David D. Kim, Kristen Harris Nwanyanwu, Mark W. Johnson & David W. Hutton. (2013) Cost-Effectiveness of Various Interventions for Newly Diagnosed Diabetic Macular Edema. Ophthalmology 120:9, pages 1835-1842.
Crossref
Crossref
Jithin Yohannan, Millena Bittencourt, Yasir Jamal Sepah, Elham Hatef, Raafay Sophie, Ahmadreza Moradi, Hongting Liu, Mohamed Ibrahim, Diana V. Do, Elizabeth Coulantuoni & Quan Dong Nguyen. (2013) Association of Retinal Sensitivity to Integrity of Photoreceptor Inner/Outer Segment Junction in Patients with Diabetic Macular Edema. Ophthalmology 120:6, pages 1254-1261.
Crossref
Crossref
Zofia Michalewska, Maciej Bednarski, Janusz Michalewski & Nawrocki Jerzy. (2013) The Role of ILM Peeling in Vitreous Surgery for Proliferative Diabetic Retinopathy Complications. Ophthalmic Surgery, Lasers and Imaging Retina 44:3, pages 238-242.
Crossref
Crossref
Benjamin J. Thomas, Gary Shienbaum, David S. Boyer & Harry W. FlynnJr.Jr.. (2013) Evolving strategies in the management of diabetic macular edema: clinical trials and current management. Canadian Journal of Ophthalmology 48:1, pages 22-30.
Crossref
Crossref
Francesco Bandello, Rosangela Lattanzio, Ilaria Zucchiatti & Claudia Del Turco. (2013) Pathophysiology and treatment of diabetic retinopathy. Acta Diabetologica 50:1, pages 1-20.
Crossref
Crossref
Diethelm Tschöpe, Markolf Hanefeld, Juris J Meier, Anselm K Gitt, Martin Halle, Peter Bramlage & Petra-Maria Schumm-Draeger. (2013) The role of co-morbidity in the selection of antidiabetic pharmacotherapy in type-2 diabetes. Cardiovascular Diabetology 12:1, pages 62.
Crossref
Crossref
Andreea Ciudin, Cristina Hernández & Rafael Simó. (2013) Molecular Implications of the PPARs in the Diabetic Eye. PPAR Research 2013, pages 1-11.
Crossref
Crossref
Cristina Hernández & Rafael Simó. (2012) Neuroprotection in Diabetic Retinopathy. Current Diabetes Reports 12:4, pages 329-337.
Crossref
Crossref
Francesco Bandello, Rosangela Lattanzio, Ilaria Zucchiatti & Paolo Lanzetta. (2012) Ask the Experts: Treating diabetic retinopathy: developments and challenges. Diabetes Management 2:3, pages 191-198.
Crossref
Crossref
F Bandello, J Cunha-Vaz, N V Chong, G E Lang, P Massin, P Mitchell, M Porta, C Prünte, R Schlingemann & U Schmidt-Erfurth. (2012) New approaches for the treatment of diabetic macular oedema: recommendations by an expert panel. Eye 26:4, pages 485-493.
Crossref
Crossref
James E. Frampton. (2012) Ranibizumab. Drugs 72:4, pages 509-523.
Crossref
Crossref
K.D. Lemmen. (2012) Individuelle Therapieziele bei diabetischer Retinopathie und MakulopathieIndividual therapy targets for diabetic retinopathy and maculopathy. Der Diabetologe 8:2, pages 149-152.
Crossref
Crossref
Olga Simó-Servat, Cristina Hernández & Rafael Simó. (2012) Usefulness of the Vitreous Fluid Analysis in the Translational Research of Diabetic Retinopathy. Mediators of Inflammation 2012, pages 1-11.
Crossref
Crossref
Robert J. Petrella, Julie Blouin, Brian Davies & Martin Barbeau. (2012) Prevalence, Demographics, and Treatment Characteristics of Visual Impairment due to Diabetic Macular Edema in a Representative Canadian Cohort. Journal of Ophthalmology 2012, pages 1-6.
Crossref
Crossref
Rui Bernardes & José Cunha-Vaz. 2012. Optical Coherence Tomography. Optical Coherence Tomography
157
174
.
Francesco Boscia. (2010) Current Approaches to the Management of Diabetic Retinopathy and Diabetic Macular Oedema. Drugs 70:16, pages 2171-2200.
Crossref
Crossref